The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Degradation of the Alzheimer's Amyloid β Peptide by Endothelin-converting Enzyme
Open accessAbstract
Deposition of beta-amyloid (Abeta) peptides in the brain is an early and invariant feature of all forms of Alzheimer's disease. As with any secreted protein, the extracellular concentration of Abeta is determined not only by its production but also by its catabolism. A major focus of Alzheimer's research has been the elucidation of the mechanisms responsible for the generation of Abeta. Much less, however, is known about the mechanisms responsible for Abeta removal in the brain. In this report, we describe the identification of endothelin-converting enzyme-1 (ECE-1) as a novel Abeta-degrading enzyme. We show that treatment of endogenous ECE-expressing cell lines with the metalloprotease inhibitor phosphoramidon causes a 2-3-fold elevation in extracellular Abeta concentration that appears to be due to inhibition of intracellular Abeta degradation. Furthermore, we show that overexpression of ECE-1 in Chinese hamster ovary cells, which lack endogenous ECE activity, reduces extracellular Abeta concentration by up to 90% and that this effect is completely reversed by treatment of the cells with phosphoramidon. Finally, we show that recombinant soluble ECE-1 is capable of hydrolyzing synthetic Abeta40 and Abeta42 in vitro at multiple sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
Self-citationXu, D., Emoto, N., Giaid, A., Slaughter, C., Kaw, S., deWit, D., & Yanagisawa, M. (1994) · Cell · doi:10.1016/0092-8674(94)90425-1 · Cited by 921
Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867
Nagase, T. (1998) · DNA Research · doi:10.1093/dnares/5.1.31 · Cited by 842
Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation
Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., & Selkoe, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32730 · Cited by 812
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 709
Emoto, N., & Yanagisawa, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15262 · Cited by 499
Vekrellis, K., Ye, Z., Qiu, W. Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. R., & Selkoe, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01657.2000 · Cited by 495
Yanagisawa, H., Yanagisawa, M., Kapur, R. P., Richardson, J. A., Williams, S. C., Clouthier, D. E., Wit, D. D., Emoto, N., & Hammer, R. E. (1998) · Development · doi:10.1242/dev.125.5.825 · Cited by 491
Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX
Turner, A. J., & Tanzawa, K. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141502 · Cited by 402
Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's Disease
Checler, F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65041431.x · Cited by 377
A full genome scan for late onset Alzheimer's disease
Kehoe, P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.237 · Cited by 357
Kurochkin, I. V., & Goto, S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00387-4 · Cited by 340
Backstrom, J. R., Lim, G. P., Cullen, M. J., & Tökés, Z. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07910.1996 · Cited by 331
[18] Peptidyl dipeptidase A: Angiotensin I-converting enzyme
Corvol, P., Williams, T. A., & Soubrier, F. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)48020-x · Cited by 277
Golde, T. E., Eckman, C. B., & Younkin, S. G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00043-0 · Cited by 244
Self-citationPérez, A., Morelli, L., Cresto, J. C., & Castaño, E. M. (2000) · Neurochemical Research · doi:10.1023/a:1007527721160 · Cited by 240
Molecular pharmacology of endothelin converting enzymes
Turner, A. J., & Murphy, L. J. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02036-5 · Cited by 235
Organization of the Gene Encoding the Human Endothelin-converting Enzyme (ECE-1)
Valdenaire, O., Rohrbacher, E., & Mattei, M.-G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29794 · Cited by 210
Howell, S., Nalbantoglu, J., & Crine, P. (1995) · Peptides · doi:10.1016/0196-9781(95)00021-b · Cited by 204
Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations
SCHWEIZER, A., VALDENAIRE, O., NELBÖCK, P., DEUSCHLE, U., DUMAS MILNE EDWARDS, J.-B., STUMPF, J. G., & LÖFFLER, B.-M. (1997) · Biochemical Journal · doi:10.1042/bj3280871 · Cited by 203
Molecular characterization of human and bovine endothelin converting enzyme (ECE‐1)
Schmidt, M., Kröger, B., Jacob, E., Seulberger, H., Subkowski, T., Otter, R., Meyer, T., Schmalzing, G., & Hillen, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01277-6 · Cited by 198
Yanagisawa, H., Hammer, R. E., Richardson, J. A., Emoto, N., Williams, S. C., Takeda, S.-I., Clouthier, D. E., & Yanagisawa, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7447 · Cited by 190
Valdenaire, O., Lepailleur‐Enouf, D., Egidy, G., Thouard, A., Barret, A., Vranckx, R., Tougard, C., & Michel, J. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00602.x · Cited by 170
The endothelin system and its potential as a therapeutic target in cardiovascular disease
Gray, G. A., & Webb, D. J. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00101-5 · Cited by 154
Long Amyloid .beta.-Protein Secreted from Wild-Type Human Neuroblastoma IMR-32 Cells
Asami-Odaka, A., Ishibashi, Y., Kikuchi, T., Kitada, C., & Suzuki, N. (1995) · Biochemistry · doi:10.1021/bi00032a022 · Cited by 148
Hydrolysis of Peptide Hormones by Endothelin-converting Enzyme-1
Johnson, G. D., Stevenson, T. I., & Ahn, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4053 · Cited by 145
Identification and characterization of two isoforms of an endothelin‐converting enzyme‐1
Shimada, K., Takahashi, M., Ikeda, M., et al. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00886-e · Cited by 119
Ikeda, K., Emoto, N., Raharjo, S. B., Nurhantari, Y., Saiki, K., Yokoyama, M., & Matsuo, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32469 · Cited by 108
Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin
Hoang, M. V., & Turner, A. J. (1997) · Biochemical Journal · doi:10.1042/bj3270023 · Cited by 106
Takaki, Y., Iwata, N., Tsubuki, S., Taniguchi, S., Toyoshima, S., Lu, B., Gerard, N. P., Gerard, C. J., Lee, H., Shirotani, K., et al. (2000) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022839 · Cited by 101
Neutral endopeptidase-24.11 inhibitors: from analgesics to antihypertensives?
Rogues, B. P., & Beaumont, A. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90252-4 · Cited by 100
Degradation of Amyloid β-Protein by a Serine Protease-α2-Macroglobulin Complex
Qiu, W. Q., Borth, W., Ye, Z., Haass, C., Teplow, D. B., & Selkoe, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8443 · Cited by 98
Chesneau, V., Vekrellis, K., Rosner, M. R., & Selkoe, D. J. (2000) · Biochemical Journal · doi:10.1042/bj3510509 · Cited by 90
Metalloendopeptidase EC 3.4.24.15 Is Necessary for Alzheimer's Amyloid-β Peptide Degradation
Yamin, R., Malgeri, E. G., Sloane, J. A., McGraw, W. T., & Abraham, C. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18777 · Cited by 88
Ahn, K., Pan, S. M., Beningo, K. A., et al. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00227-w · Cited by 85
Fuller, S. J., Storey, E., Li, Q.-X., Smith, A. I., Beyreuther, K., & Masters, C. L. (1995) · Biochemistry · doi:10.1021/bi00025a015 · Cited by 80
Ghaddar, G., Ruchon, A. F., Carpentier, M., Marcinkiewicz, M., Seidah, N. G., Crine, P., DesGroseillers, L., & Boileau, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470419 · Cited by 79
Spillantini, M. G., Sicuteri, F., Salmon, S., et al. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90012-a · Cited by 67
Neprilysin II: A Putative Novel Metalloprotease and Its Isoforms in CNS and Testis
Ouimet, T., Facchinetti, P., Rose, C., Bonhomme, M.-C., Gros, C., & Schwartz, J.-C. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2664 · Cited by 57
Emoto, N., Nurhantari, Y., Alimsardjono, H., Xie, J., Yamada, T., Yanagisawa, M., & Matsuo, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1509 · Cited by 50
Takagi, G., Kiuchi, K., Endo, T., et al. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200007000-00003 · Cited by 49
Novel Selective Quinazoline Inhibitors of Endothelin Converting Enzyme-1
Ahn, K., Sisneros, A. M., Herman, S. B., Pan, S. M., HUPE, D. J., Lee, C., Nikam, S. S., Cheng, X.-M., Doherty, A. M., Schroeder, R. L., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8081 · Cited by 45
Russell, F. D., & Davenport, A. P. (1999) · Circulation Research · doi:10.1161/01.res.84.8.891 · Cited by 38
Ahn, K., Herman, S. B., & Fahnoe, D. C. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0913 · Cited by 38
Barnes, K., Walkden, B. J., Wilkinson, T. C., & Turner, A. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020570.x · Cited by 38
A Live-Cell Assay for Studying Extracellular and Intracellular Endothelin-Converting Enzyme Activity
Parnot, C., le Moullec, J.-M., Cousin, M., Guédin, D., Corvol, P. L., & Pinet, F. (1997) · Hypertension · doi:10.1161/01.hyp.30.4.837 · Cited by 32
Endothelin-converting enzyme in human tissues
Davenport, A. P., Kuc, R. E., Plumpton, C., Mockridge, J. W., Barker, P. J., & Huskisson, N. S. (1998) · The Histochemical Journal · doi:10.1023/a:1003236628701 · Cited by 31
Cerebrospinal fluid endothelin-1 in Alzheimer's disease and senile dementia of Alzheimer type
Yoshizawa, T., Iwamoto, H., Mizusawa, H., et al. (1992) · Neuropeptides · doi:10.1016/0143-4179(92)90059-6 · Cited by 20
Cailler, F., Zappulla, J. P., Boileau, G., & Crine, P. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3410119 · Cited by 17
Soleilhac, J.-M., Lafuma, C., Porcher, J., Auburtin, G., & Roques, B. P. (1996) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1996.2420580.x · Cited by 17
Cited by
Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development
Chen, G.-F., Xu, T.-H., Yan, Y., Zhou, Y.-R., Jiang, Y., Melcher, K., & Xu, H. E. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.28 · Cited by 1,965
Clearance systems in the brain—implications for Alzheimer disease
Tarasoff-Conway, J. M., Carare, R. O., Osorio, R. S., Glodzik, L., Butler, T., Fieremans, E., Axel, L., Rusinek, H., Nicholson, C., Zlokovic, B. V., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.119 · Cited by 1,678
Autophagy, amyloidogenesis and Alzheimer disease
Nixon, R. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.019265 · Cited by 749
Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
Barage, S. H., & Sonawane, K. D. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.06.008 · Cited by 579
Clearing the brain's amyloid cobwebs
Selkoe, D. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00475-5 · Cited by 541
Metadata
- Authors
- Eckman, E. A., Reed, D. K., & Eckman, C. B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 276
- Issue
- 27
- Pages
- 24540-24548
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2019042091
- Cited by
- 342
- References
- 51
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.